Skip to main content

AIDS Vaccines: Exploring the Potential Cost/Benefit

May 18, 2012
This Policy Brief explores the potential cost savings an AIDS vaccine could create by averting new HIV infections and reducing the number of new patients requiring antiretroviral treatment.
If you have Adobe PDF Viewer, you can browse the publication below.
Otherwise click here to download the PDF in English.